Back

Tecarfarin pharmacokinetics and pharmacodynamics-A novel CYP2C9 independent vitamin K antagonist

29 August 2016 (10:40 - 10:47)
Organised by:
Congress Presentation Part of: Insights on thrombosis and anticoagulants Thrombosis and coagulation ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Mark Midei

Armetheon, Monkton (United States of America)

5 More presentations in this session

Presentation thumbnail
Familial clustering of venous thromboembolism - A Danish nationwide cohort study
Ms C. Sindet-Pedersen (Hellerup, DK)
Abstract
Presentation thumbnail
Inhibitory effects of ticagrelor monotherapy on arachidonic acid induced platelet aggregation in patients with coronary heart disease
Doctor J. Jiang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Contemporary registry of intermediate and high risk pulmonary embolism patients presenting to a large tertiary medical center
Doctor R. Beigel (Ramat Gan, IL)
Abstract
Presentation thumbnail
Markers of thrombin generation in patients with ST-elevation myocardial infarction are associated with long term clinical outcome
Mrs C. Hansen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Presence of bacterial DNA in thrombus aspirates of patients with myocardial infarction.
Doctor P. Pinon (Pontevedra, ES)
Abstract Slides

Access the full session

Session thumbnail
Insights on thrombosis and anticoagulants

The Event

Event poster

ESC Congress 2016

29 August 2016 10:40 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources